Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...
Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...